Barinthus Biotherapeutics Plc Stock Shares Outstanding
| BRNS Stock | 1.04 0.03 2.97% |
Barinthus Biotherapeutics plc fundamentals help investors to digest information that contributes to Barinthus Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Barinthus Stock. The fundamental analysis module provides a way to measure Barinthus Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Barinthus Biotherapeutics stock.
Common Stock Shares Outstanding is likely to drop to about 32.5 M in 2025. Barinthus | Shares Outstanding |
Barinthus Biotherapeutics plc Company Shares Outstanding Analysis
Barinthus Biotherapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Barinthus Biotherapeutics Shares Outstanding | 40.23 M |
Most of Barinthus Biotherapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Barinthus Biotherapeutics plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Barinthus Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Barinthus Biotherapeutics is extremely important. It helps to project a fair market value of Barinthus Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Barinthus Biotherapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Barinthus Biotherapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Barinthus Biotherapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Barinthus Shares Outstanding Historical Pattern
Today, most investors in Barinthus Biotherapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Barinthus Biotherapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Barinthus Biotherapeutics shares outstanding as a starting point in their analysis.
Barinthus Biotherapeutics Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Barinthus Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Barinthus Biotherapeutics plc has 40.23 M of shares currently outstending. This is 77.72% lower than that of the Biotechnology sector and 62.35% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 92.96% higher than that of the company.
Barinthus Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Barinthus Biotherapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Barinthus Biotherapeutics could also be used in its relative valuation, which is a method of valuing Barinthus Biotherapeutics by comparing valuation metrics of similar companies.Barinthus Biotherapeutics is currently under evaluation in shares outstanding category among its peers.
Barinthus Fundamentals
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.19 | ||||
| Operating Margin | (0.61) % | ||||
| Current Valuation | (51.6 M) | ||||
| Shares Outstanding | 40.23 M | ||||
| Shares Owned By Insiders | 10.98 % | ||||
| Shares Owned By Institutions | 46.22 % | ||||
| Number Of Shares Shorted | 12.37 K | ||||
| Price To Book | 0.26 X | ||||
| Price To Sales | 2.79 X | ||||
| Revenue | 802 K | ||||
| Gross Profit | (30.12 M) | ||||
| EBITDA | (71.06 M) | ||||
| Net Income | (73.63 M) | ||||
| Total Debt | 12.98 M | ||||
| Book Value Per Share | 4.03 X | ||||
| Cash Flow From Operations | (50.92 M) | ||||
| Short Ratio | 0.33 X | ||||
| Earnings Per Share | (1.49) X | ||||
| Target Price | 6.25 | ||||
| Number Of Employees | 130 | ||||
| Beta | -0.58 | ||||
| Market Capitalization | 41.84 M | ||||
| Total Asset | 214.51 M | ||||
| Retained Earnings | (176.59 M) | ||||
| Working Capital | 144.31 M | ||||
| Net Asset | 214.51 M |
About Barinthus Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Barinthus Biotherapeutics plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Barinthus Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Barinthus Biotherapeutics plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Barinthus Stock Analysis
When running Barinthus Biotherapeutics' price analysis, check to measure Barinthus Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barinthus Biotherapeutics is operating at the current time. Most of Barinthus Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Barinthus Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barinthus Biotherapeutics' price. Additionally, you may evaluate how the addition of Barinthus Biotherapeutics to your portfolios can decrease your overall portfolio volatility.